[Results of clinical studies on the prophylactic and therapeutic effectiveness of oxoline on artificially induced influenza A2 infection in volunteers].
D000336:Aerosols; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D005334:Fever / Q000188:drug therapy; D006801:Humans; D006940:Hyperemia / Q000517:prevention & control; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D009281:Naphthalenes / Q000008:administration & dosage / Q000627:therapeutic use*; D009297:Nasal Mucosa / Q000187:drug effects; D009824:Ointments; D012220:Rhinitis / Q000517:prevention & control; D013764:Tetrahydronaphthalenes; D013997:Time Factors
D000336:Aerosols; D000906:Antibodies; D007252:Influenza Vaccines; D009281:Naphthalenes; D009824:Ointments; D013764:Tetrahydronaphthalenes; C003020:oxoline
Rezul'taty klinicheskikh ispytaniĭ profilakticheskoĭ i terapevticheskoĭ effectivnosti oksolin na iskusstvenno vyzvannoĭ u dobrovol'tsev grippoznoĭ infektsii A2.